Home › Sezary Syndrome › Massachusetts › Boston
Sezary Syndrome clinical trials in Boston, MA
4 studies for Sezary Syndrome are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
RecruitingObservational study
- Brigham and Women's Hospital, Boston
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Sezary Syndrome trials in other cities
- Baldwin Park, CA7 studies
- Mountain View, CA5 studies
- Houston, TX4 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Tampa, FL3 studies
- Philadelphia, PA3 studies
- St. Louis, MO3 studies
- Pittsburgh, PA3 studies
Other studies in Boston
- Breast Cancer112 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)85 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.